Sotabase

Career

· Professor, Tufts University (Current)1981–
· Associate Professor, Northeastern University
· PhD, Vanderbilt University School of Medicine

Publications (254)

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic‐Cell Transplantation
New England Journal of Medicine · 2017
962
cited
Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients
American Journal of Transplantation · 2004
830
cited
Outcomes of kidney transplantation in HIV-infected recipients.
New England Journal of Medicine · 2010
515
cited
Long‐term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
Liver transplantation · 2013
479
cited
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients
American Journal of Transplantation · 2010
473
cited
COVID-19 in solid organ transplant: A multi-center cohort study
Clinical Infectious Diseases · 2020
332
cited
Common infections in kidney transplant recipients.
American Society of Nephrology. Clinical Journal · 2012
231
cited
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome.
Journal of Infectious Diseases · 2009
224
cited
Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management
American Journal of Transplantation · 2015
213
cited
Donor‐Derived Disease Transmission Events in the United States: Data Reviewed by the OPTN/UNOS Disease Transmission Advisory Committee
American Journal of Transplantation · 2009
211
cited
The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium
1999
204
cited
The immunogenicity of influenza virus vaccine in solid organ transplant recipients.
Clinical Infectious Diseases · 1996
203
cited
Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study
Transplantation · 2010
202
cited
Pharmacodynamics of Oral Ganciclovir and Valganciclovir in Solid Organ Transplant Recipients
Transplantation · 2005
174
cited
Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations †
American Journal of Transplantation · 2011
170
cited
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients.
Journal of Infectious Diseases · 2004
165
cited
Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report
American Journal of Transplantation · 2010
165
cited
Coronavirus disease 2019: Implications of emerging infections for transplantation
American Journal of Transplantation · 2020
164
cited
A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients
Clinical Infectious Diseases · 2018
161
cited
The Report of a National Conference on the Wait List for Kidney Transplantation
American Journal of Transplantation · 2003
155
cited
Sotabase
Oscar Blumberg | Researcher Profile | Sotabase | Sotabase